Table 3.

Selected coagulation and clinical chemistry data




Age, months

Fibrinogen level, g/L

Prothrombin time, s

Total bilirubin level, μM

Potassium level, mM

Free hemoglobin level, mg/L
Wild-type        
  1   ND   ND   ND   ND   879.5 ± 303.3  
  2   1.7 ± 0.9   11.8 ± 0.9   <2   4.2 ± 1.1   747.7 ± 778.6  
  4   1.3 ± 0.4   11.6 ± 0.9   <2   4.3 ± 1.5   633.8 ± 339.8  
  6   1.5 ± 0.7   12.0 ± 1.1   <2   4.5 ± 1.2   199.3 ± 96.4  
  8   1.4 ± 0.5   11.6 ± 0.9   <2   4.7 ± 1.8   395.8 ± 182.5  
Transgenic        
  1   ND   ND   <2   ND   1531.3 ± 1025.4  
  2   1.5 ± 0.7   16.6 ± 0.7*  <2   5.3 ± 0.8   1794.6 ± 1506.6  
  4   1.7 ± 1.1   17.5 ± 1.7*  <2   5.1 ± 1.3   9000.0 ± 2642.0* 
  6   1.5 ± 0.7   17.1 ± 0.9*  <2   4.8 ± 1.2   3317.5 ± 62.9* 

 
8
 
1.3 ± 0.8
 
17.6 ± 2.3*
 
4.5 ± 2.2
 
4.3 ± 1.2
 
5613.3 ± 3940.8
 



Age, months

Fibrinogen level, g/L

Prothrombin time, s

Total bilirubin level, μM

Potassium level, mM

Free hemoglobin level, mg/L
Wild-type        
  1   ND   ND   ND   ND   879.5 ± 303.3  
  2   1.7 ± 0.9   11.8 ± 0.9   <2   4.2 ± 1.1   747.7 ± 778.6  
  4   1.3 ± 0.4   11.6 ± 0.9   <2   4.3 ± 1.5   633.8 ± 339.8  
  6   1.5 ± 0.7   12.0 ± 1.1   <2   4.5 ± 1.2   199.3 ± 96.4  
  8   1.4 ± 0.5   11.6 ± 0.9   <2   4.7 ± 1.8   395.8 ± 182.5  
Transgenic        
  1   ND   ND   <2   ND   1531.3 ± 1025.4  
  2   1.5 ± 0.7   16.6 ± 0.7*  <2   5.3 ± 0.8   1794.6 ± 1506.6  
  4   1.7 ± 1.1   17.5 ± 1.7*  <2   5.1 ± 1.3   9000.0 ± 2642.0* 
  6   1.5 ± 0.7   17.1 ± 0.9*  <2   4.8 ± 1.2   3317.5 ± 62.9* 

 
8
 
1.3 ± 0.8
 
17.6 ± 2.3*
 
4.5 ± 2.2
 
4.3 ± 1.2
 
5613.3 ± 3940.8
 

Time course of some coagulation and clinical chemistry data of transgenic animals and age-matched controls; n = 3 to 6 per group.

ND indicates not determined.

*

P < 0.01.

P < 0.001 for age-matched intergroup comparison.

Close Modal

or Create an Account

Close Modal
Close Modal